Daniel Schlanger, Current Executive Vice President and CFO, Appointed Interim President and CEO Search Underway to Identify Successor CEO Reaffirms […]
HUNTSVILLE, March 24, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its […]